Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patient selection is key in IMbassador250.

Literature DB >> 35091722

Patient selection is key in IMbassador250.

Annette Fenner¹.

Abstract

Entities: Chemical

Mesh：
Humans
Patient Selection

Year: 2022 PMID： 35091722 DOI： 10.1038/s41585-022-00572-7

Source DB: PubMed Journal: Nat Rev Urol ISSN： 1759-4812 Impact factor: 14.432

× No keyword cloud information.

1 in total

1. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.

Authors: Thomas Powles; Kobe C Yuen; Silke Gillessen; Edward E Kadel; Dana Rathkopf; Nobuaki Matsubara; Charles G Drake; Karim Fizazi; Josep M Piulats; Piotr J Wysocki; Gary L Buchschacher; Boris Alekseev; Begoña Mellado; Bogusława Karaszewska; Jennifer F Doss; Grozdana Rasuo; Asim Datye; Sanjeev Mariathasan; Patrick Williams; Christopher J Sweeney
Journal: Nat Med Date: 2022-01-10 Impact factor: 87.241

1 in total

Review 1. The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer.

Authors: Pengfei Xu; Logan J Wasielewski; Joy C Yang; Demin Cai; Christopher P Evans; William J Murphy; Chengfei Liu
Journal: Biomedicines Date: 2022-07-22

1 in total